cyproheptadine hydrochloride

Generic: cyproheptadine hydrochloride

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cyproheptadine hydrochloride
Generic Name cyproheptadine hydrochloride
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cyproheptadine hydrochloride 4 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-805
Product ID 16571-805_93f4f73b-1ff4-4a64-a8ec-4a574abc3dd6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207555
Listing Expiration 2026-12-31
Marketing Start 2022-02-09

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571805
Hyphenated Format 16571-805

Supplemental Identifiers

RxCUI
866144
UNII
NJ82J0F8QC

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cyproheptadine hydrochloride (source: ndc)
Generic Name cyproheptadine hydrochloride (source: ndc)
Application Number ANDA207555 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (16571-805-01)
  • 1000 TABLET in 1 BOTTLE (16571-805-10)
source: ndc

Packages (2)

16571-805-01 100 TABLET in 1 BOTTLE (16571-805-01) 16571-805-10 1000 TABLET in 1 BOTTLE (16571-805-10)

Ingredients (1)

cyproheptadine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Cyproheptadine Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "93f4f73b-1ff4-4a64-a8ec-4a574abc3dd6", "openfda": {"unii": ["NJ82J0F8QC"], "rxcui": ["866144"], "spl_set_id": ["c5e9e983-d0d2-4f87-beae-0d853ca43983"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-805-01)", "package_ndc": "16571-805-01", "marketing_start_date": "20220210"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (16571-805-10)", "package_ndc": "16571-805-10", "marketing_start_date": "20220210"}], "brand_name": "Cyproheptadine Hydrochloride", "product_id": "16571-805_93f4f73b-1ff4-4a64-a8ec-4a574abc3dd6", "dosage_form": "TABLET", "product_ndc": "16571-805", "generic_name": "Cyproheptadine Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cyproheptadine Hydrochloride", "active_ingredients": [{"name": "CYPROHEPTADINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA207555", "marketing_category": "ANDA", "marketing_start_date": "20220209", "listing_expiration_date": "20261231"}